'''Weight coming back after a procedure is common, and it is not a verdict on you.''' This page is what the research says and what people talk to their teams about.
== How common ==
"Fifteen to forty% of patients experience recurrent weight gain (RWG) after metabolic bariatric surgery" (Osorio Manyari AA et al., ''Obesity Surgery'', 2025 · [https://doi.org/10.1007/s11695-025-08414-2 doi:10.1007/s11695-025-08414-2]).
That range is wide because the studies define it differently and follow people for different lengths of time. What it is not is unusual.
== Why it happens ==
It is multifactorial: the anatomy adapts, appetite signaling changes again, habits drift as life does, and the same biology that made weight difficult before surgery did not go anywhere. The 2022 indications statement treats severe obesity as a chronic disease precisely because of this: long-term management "may include revisional surgery or other adjuvant therapy to achieve desired treatment effect" (Eisenberg D et al., ''Obesity Surgery'', 2023 · [https://doi.org/10.1007/s11695-022-06332-1 doi:10.1007/s11695-022-06332-1]).
== What has been studied ==
'''Re-engaging with a bariatric team.''' The things that worked the first time: the follow-up, the dietitian, the protein and the activity.
'''Weight-management medication.''' In a study of people treated for weight recurrence after a sleeve, mean weight loss at six months was 10.3% with semaglutide and 15.5% with tirzepatide (Jamal M et al., ''Obesity Surgery'', 2024 · [https://doi.org/10.1007/s11695-024-07137-0 doi:10.1007/s11695-024-07137-0]). A 2025 meta-analysis of eight studies and 964 patients found total weight loss of −10.97% for semaglutide and −13.63% for tirzepatide (Osorio Manyari AA et al., ''Obesity Surgery'', 2025 · [https://doi.org/10.1007/s11695-025-08414-2 doi:10.1007/s11695-025-08414-2]). The first study also notes that "weight regain after discontinuation of the medication is highly likely" (Jamal M et al., ''Obesity Surgery'', 2024 · [https://doi.org/10.1007/s11695-024-07137-0 doi:10.1007/s11695-024-07137-0]).
'''Endoscopic revision.''' Sometimes an option, depending on the original procedure and what is found.
== What Loopa does ==
If your weight rises 10% or more from its lowest point since your procedure, Loopa offers you this reading and an appointment-prep export: your stage history, your protein and fluid averages, your supplement adherence, your symptom log and your weight trend, ready to hand over.
'''It recommends nothing.''' It does not tell you to take a medicine, does not suggest a revision, and does not decide anything is wrong. It puts what you have recorded in front of the person qualified to read it.
The 10% figure is a threshold for showing you a card. It is not a diagnosis, and nobody else is notified.
== Related ==
- [[long-term-follow-up-and-labs|Long-term follow-up and labs]]
- [[non-surgical-medical-weight-management|Non-surgical medical weight management]]
- [[medication-protocols|Medication protocols]]
== Where this comes from ==
Everything on this page is drawn from published clinical guidelines and peer-reviewed research, cited above. '''Loopa does not give medical advice.''' It does not decide whether a procedure is right for you, does not recommend one over another, and never sets a dose. Your care team does all three, and where they give you an instruction, theirs is the one to follow.
'''Weight coming back after a procedure is common, and it is not a verdict on you.''' This page is what the research says and what people talk to their teams about. == How common == "Fifteen to forty% of patients experience recurrent weight gain (RWG) after metabolic bariatric surgery" (Osorio Manyari AA et al., ''Obesity Surgery'', 2025 · [https://doi.org/10.1007/s11695-025-08414-2 doi:10.1007/s11695-025-08414-2]). That range is wide because the studies define it differently and follow people for different lengths of time. What it is not is unusual. == Why it happens == It is multifactorial: the anatomy adapts, appetite signaling changes again, habits drift as life does, and the same biology that made weight difficult before surgery did not go anywhere. The 2022 indications statement treats severe obesity as a chronic disease precisely because of this: long-term management "may include revisional surgery or other adjuvant therapy to achieve desired treatment effect" (Eisenberg D et al., ''Obesity Surgery'', 2023 · [https://doi.org/10.1007/s11695-022-06332-1 doi:10.1007/s11695-022-06332-1]). == What has been studied == '''Re-engaging with a bariatric team.''' The things that worked the first time: the follow-up, the dietitian, the protein and the activity. '''Weight-management medication.''' In a study of people treated for weight recurrence after a sleeve, mean weight loss at six months was 10.3% with semaglutide and 15.5% with tirzepatide (Jamal M et al., ''Obesity Surgery'', 2024 · [https://doi.org/10.1007/s11695-024-07137-0 doi:10.1007/s11695-024-07137-0]). A 2025 meta-analysis of eight studies and 964 patients found total weight loss of −10.97% for semaglutide and −13.63% for tirzepatide (Osorio Manyari AA et al., ''Obesity Surgery'', 2025 · [https://doi.org/10.1007/s11695-025-08414-2 doi:10.1007/s11695-025-08414-2]). The first study also notes that "weight regain after discontinuation of the medication is highly likely" (Jamal M et al., ''Obesity Surgery'', 2024 · [https://doi.org/10.1007/s11695-024-07137-0 doi:10.1007/s11695-024-07137-0]). '''Endoscopic revision.''' Sometimes an option, depending on the original procedure and what is found. == What Loopa does == If your weight rises 10% or more from its lowest point since your procedure, Loopa offers you this reading and an appointment-prep export: your stage history, your protein and fluid averages, your supplement adherence, your symptom log and your weight trend, ready to hand over. '''It recommends nothing.''' It does not tell you to take a medicine, does not suggest a revision, and does not decide anything is wrong. It puts what you have recorded in front of the person qualified to read it. The 10% figure is a threshold for showing you a card. It is not a diagnosis, and nobody else is notified. == Related == * [[long-term-follow-up-and-labs|Long-term follow-up and labs]] * [[non-surgical-medical-weight-management|Non-surgical medical weight management]] * [[medication-protocols|Medication protocols]] == Where this comes from == Everything on this page is drawn from published clinical guidelines and peer-reviewed research, cited above. '''Loopa does not give medical advice.''' It does not decide whether a procedure is right for you, does not recommend one over another, and never sets a dose. Your care team does all three, and where they give you an instruction, theirs is the one to follow.
